European equities traded in the US as American depositary receipts were tracking higher late Friday morning, rising 0.99% to 1,916.06 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by consumer goods company Unilever (UL) and petroleum refiner Equinor (EQNR), which rose 2.3% each. They were followed by medical device maker EDAP TMS (FOCL) and biotech firm Evaxion (EVAX), which advanced 1.6% and 1.4%, respectively.
The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies (DBVT) and argenx (ARGX), which fell 3.5% and 2.8%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and biotech firm BioNTech (BNTX), which dropped 2.3% and 1.2%, respectively.
The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and hospitality company InterContinental Hotels Group (IHG), which increased 6.9% and 3%, respectively. They were followed by tobacco company British American Tobacco (BTI) and alcoholic beverage company Diageo (DEO), which rose 2.7% and 2.5%, respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biotech firm Autolus Therapeutics (AUTL), which fell 3.2% and 2.9%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and biopharmaceutical company Mereo BioPharma Group (MREO), which dropped 2.1% and 1.2%, respectively.
